AngioDynamics (NASDAQ:ANGO) Announces FY 2027 Earnings Guidance

AngioDynamics (NASDAQ:ANGO) Announces FY 2027 Earnings Guidance

AngioDynamics (NASDAQ:ANGO) updated its FY 2027 earnings guidance. The company provided EPS guidance of -0.290--0.240 for the period, compared to the consensus estimate of -0.260. The company also issued revenue guidance of $336.0 million-$341.0 million, compared to the consensus estimate of $337.6 million.

AngioDynamics: Fiscal Q1 Earnings Snapshot

LATHAM, N.Y. (AP) — LATHAM, N.Y. (AP) — AngioDynamics Inc. (ANGO) on Thursday reported a loss of $7.1 million in its fiscal first quarter.

AngioDynamics Beats Estimates With $80.92 Million Q1 Revenue

The medical-device company posted non-GAAP earnings of negative 4 cents per share and reaffirmed its fiscal 2026 outlook.